Scilex Holding (SCLXW) Payables (2020 - 2026)
Scilex Holding (SCLXW) recorded quarterly Payables of $101.6 million in Q1 2026, up 17.75% quarter-over-quarter from $86.3 million in Q4 2025, and up 77.41% on a YoY basis from $57.3 million in Q1 2025.
Scilex Holding (SCLXW) Payables (2020 - 2026) Analysis & Trends
Scilex Holding's Payables history runs 7 years deep, the most recent figure standing at $101.6 million for Q1 2026.
- In Q1 2026, Payables rose 77.41% year-over-year to $101.6 million; the TTM figure through Mar 2026 stood at $101.6 million (up 77.41% YoY), while the FY2025 annual figure was $86.3 million, up 63.94% from the prior year.
- Payables was $101.6 million for Q1 2026 at Scilex Holding, up from $86.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $101.6 million in Q1 2026 to a low of $41003.0 in Q1 2022.
- Historically, Payables has averaged $30.8 million across 5 years, with a median of $9.8 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Payables tumbled 99.67% in 2022, then soared 53473.08% in 2024.
- A 5-year view of Payables shows it stood at $79000.0 in 2022, then jumped by 254.43% to $280000.0 in 2023, then surged by 18692.86% to $52.6 million in 2024, then soared by 63.94% to $86.3 million in 2025, then advanced by 17.75% to $101.6 million in 2026.
- The last three Payables figures came in at $101.6 million (Q1 2026), $86.3 million (Q4 2025), and $68.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -26.13 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 5.03 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 27.92 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 33.77 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 6.01 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 2.94 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 645.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 4.51 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 4.23 Bn |
| 10 | Scilex Holding | - | - | 4.15 Mn | 101.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.58 Mn |
| Dec 31, 2025 | 86.27 Mn |
| Sep 30, 2025 | 68.16 Mn |
| Jun 30, 2025 | 59.16 Mn |
| Mar 31, 2025 | 57.26 Mn |
| Dec 31, 2024 | 52.62 Mn |
| Sep 30, 2024 | 346,000.00 |
| Jun 30, 2024 | 41.79 Mn |
| Mar 31, 2024 | 42.22 Mn |
| Dec 31, 2023 | 280,000.00 |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | 78,000.00 |
| Mar 31, 2023 | 9.82 Mn |
| Dec 31, 2022 | 79,000.00 |
| Sep 30, 2022 | 809,292.00 |
| Jun 30, 2022 | 598,646.00 |
| Mar 31, 2022 | 41,003.00 |
| Dec 31, 2021 | 23.89 Mn |
| Sep 30, 2021 | 43,569.00 |
| Jun 30, 2021 | 20,025.00 |